The role of maintenance therapy in multiple myeloma

por Lipe, B, Vukas, R, Mikhael, J
Publicado 2016

Canadian supportive care recommendations for the management of anemia in patients with cancer

por Mikhael, J., Melosky, B., Cripps, C., Rayson, D., Kouroukis, C.T.
Publicado 2007

Canadian supportive care recommendations for the management of neutropenia in patients with cancer

por Kouroukis, C.T., Chia, S., Verma, S., Robson, D., Desbiens, C., Cripps, C., Mikhael, J.
Publicado 2008

Health care utilization and mortality among elderly patients with myelodysplastic syndromes

por Lindquist, K. J., Danese, M. D., Mikhael, J., Knopf, K. B., Griffiths, R. I.
Publicado 2011

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma

por Chanan-Khan, A A, Swaika, A, Paulus, A, Kumar, S K, Mikhael, J R, Rajkumar, S V, Dispenzieri, A, Lacy, M Q
Publicado 2013

Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?

por Rosenthal, A, Luthi, J, Belohlavek, M, Kortüm, K M, Mookadam, F, Mayo, A, Fonseca, R, Bergsagel, P L, Reeder, C B, Mikhael, J R, Stewart, A K
Publicado 2016

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

por Kumar, S K, LaPlant, B, Roy, V, Reeder, C B, Lacy, M Q, Gertz, M A, Laumann, K, Thompson, M A, Witzig, T E, Buadi, F K, Rivera, C E, Mikhael, J R, Bergsagel, P L, Kapoor, P, Hwa, L, Fonseca, R, Stewart, A K, Chanan-Khan, A, Rajkumar, S V, Dispenzieri, A
Publicado 2015